Sewoon Medical Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sewoon Medical.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Medical Equipment winstgroei | 33.5% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Does Sewoon Medical (KOSDAQ:100700) Deserve A Spot On Your Watchlist?
May 13Is Sewoon Medical (KOSDAQ:100700) Likely To Turn Things Around?
Mar 08How Does Sewoon Medical Co., Ltd (KOSDAQ:100700) Stand Up To These Simple Dividend Safety Checks?
Feb 18What Type Of Shareholders Own The Most Number of Sewoon Medical Co., Ltd (KOSDAQ:100700) Shares?
Jan 31Sewoon Medical Co., Ltd's (KOSDAQ:100700) Stock Is Going Strong: Have Financials A Role To Play?
Jan 12Sewoon Medical (KOSDAQ:100700) Shareholders Have Enjoyed A 93% Share Price Gain
Dec 24Will Sewoon Medical (KOSDAQ:100700) Multiply In Value Going Forward?
Dec 06In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Sewoon Medical onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 64,875 | 14,145 | 15,142 | 16,857 | N/A |
3/31/2024 | 67,205 | 14,849 | 20,556 | 22,410 | N/A |
12/31/2023 | 68,247 | 14,957 | 21,120 | 23,076 | N/A |
9/30/2023 | 67,251 | 14,233 | 21,546 | 23,065 | N/A |
6/30/2023 | 64,694 | 12,722 | 17,831 | 19,718 | N/A |
3/31/2023 | 62,512 | 11,771 | 10,088 | 12,089 | N/A |
12/31/2022 | 60,116 | 10,406 | 7,111 | 9,279 | N/A |
9/30/2022 | 60,272 | 10,759 | 6,523 | 9,410 | N/A |
6/30/2022 | 61,114 | 11,152 | 9,870 | 12,936 | N/A |
3/31/2022 | 61,649 | 11,339 | 16,169 | 19,019 | N/A |
12/31/2021 | 62,579 | 12,282 | 18,979 | 21,469 | N/A |
9/30/2021 | 61,452 | 10,707 | 17,804 | 21,011 | N/A |
6/30/2021 | 60,664 | 10,385 | 17,962 | 21,336 | N/A |
3/31/2021 | 62,908 | 10,170 | 17,922 | 21,190 | N/A |
12/31/2020 | 63,729 | 10,209 | 15,764 | 19,252 | N/A |
9/30/2020 | 65,540 | 10,974 | 16,575 | 18,615 | N/A |
6/30/2020 | 66,592 | 11,870 | 12,081 | 16,055 | N/A |
3/31/2020 | 66,379 | 14,442 | 8,521 | 13,541 | N/A |
12/31/2019 | 66,869 | 13,973 | 7,521 | 13,481 | N/A |
9/30/2019 | 65,599 | 17,721 | 5,283 | 12,413 | N/A |
6/30/2019 | 64,421 | 16,702 | 7,296 | 13,253 | N/A |
3/31/2019 | 63,368 | 14,082 | 6,566 | 12,893 | N/A |
12/31/2018 | 63,121 | 13,808 | 7,027 | 12,195 | N/A |
9/30/2018 | 62,587 | 10,763 | 8,756 | 13,299 | N/A |
6/30/2018 | 63,356 | 10,397 | 5,809 | 10,673 | N/A |
3/31/2018 | 61,447 | 9,556 | N/A | 9,769 | N/A |
12/31/2017 | 61,230 | 9,177 | N/A | 8,229 | N/A |
9/30/2017 | 59,574 | 7,809 | N/A | 7,412 | N/A |
6/30/2017 | 58,071 | 7,565 | N/A | 9,406 | N/A |
3/31/2017 | 57,757 | 8,694 | N/A | 6,833 | N/A |
12/31/2016 | 56,620 | 8,349 | N/A | 6,349 | N/A |
9/30/2016 | 57,619 | 9,052 | N/A | 3,472 | N/A |
6/30/2016 | 56,517 | 3,968 | N/A | 646 | N/A |
3/31/2016 | 56,058 | 3,321 | N/A | 2,630 | N/A |
12/31/2015 | 55,867 | 3,064 | N/A | 3,652 | N/A |
9/30/2015 | 54,944 | 1,345 | N/A | 6,186 | N/A |
6/30/2015 | 55,092 | 6,456 | N/A | 6,948 | N/A |
3/31/2015 | 53,647 | 5,162 | N/A | 8,637 | N/A |
12/31/2014 | 52,871 | 5,992 | N/A | 8,402 | N/A |
9/30/2014 | 52,589 | 8,145 | N/A | 7,769 | N/A |
6/30/2014 | 52,100 | 7,964 | N/A | 8,908 | N/A |
3/31/2014 | 52,604 | 9,192 | N/A | 8,087 | N/A |
12/31/2013 | 51,423 | 8,519 | N/A | 9,619 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if A100700's forecast earnings growth is above the savings rate (2.6%).
Winst versus markt: Insufficient data to determine if A100700's earnings are forecast to grow faster than the KR market
Hoge groeiwinsten: Insufficient data to determine if A100700's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if A100700's revenue is forecast to grow faster than the KR market.
Hoge groei-inkomsten: Insufficient data to determine if A100700's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if A100700's Return on Equity is forecast to be high in 3 years time